The effect of postmenopausal estrogen therapy on the risk of non- insulin-dependent diabetes mellitus

American Journal of Public Health

Volumn 87, Issue 3, 1997, Pages 443-445

  Gabal, Lamia L ^a   Goodman Gruen, Deborah ^a   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; RISK ASSESSMENT;

EID: 0030908383     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.87.3.443     Document Type: Article

References (22)

1. Paoletti R, Gotto AM Jr, eds. Volume 4: Atherosclerosis Reviews. New York, NY: Raven Press; 1979:157-235.
2. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J. Factors of risk in the development of coronary heart disease -six year follow-up experience. The Framingham study. Ann Intern Med. 1961; 55:33-49.
3. Pearson TA, Bulkley BH, Achuff SC, Kwiterovich PO, Gordis L. The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol. 1979;109:285-294.
4. Scheidt-Nave C, Barrett-Connor E, Wingard D, Cohn BA, Edelstein SL. Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol. 1979;133:565-576.
5. Douglas PS, Brest AN. eds. Heart Disease in Women. Philadelphia, Pa: FA Davis Co; 1989:127-143.
6. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non-contraceptive estrogen use in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1108.
7. Ross RK, Paganini-Hill A, Mack TM, Arthur M, Hendersen BE. Menopausal estrogen therapy and protection from death from ischemic heart disease. Lancet. 1981; 1:858-860.
8. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol. 1979;54:74-79.
9. Beard CM, Kottke TE, Annegers JF, Ballard DJ. The Rochester coronary heart disease project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40-59-year-old women, 1960 through 1982. Mayo Clin Proc. 1989;64:1471-1479.
10. Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy. Am J Obstet Gynecol. 1979;133:525-536.
11. Manson JE, Rimm EB. Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus. Ann Epidemiol. 1992;2:665-673.
12. SAS User's Guide, Version 6, Fourth Edition. Cary, NC: SAS Institute Inc; 1989.
13. Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;34:187-220.
14. Despres JP. Abdominal obesity as an important component of insulin-resistance syndrome. Nutrition. 1993:9:452-459.
15. Bray GA. Obesity increases risk for diabetes. Int J Obes. 1992;4(suppl):513-517.
16. Ramsay LE, Yeo WW, Jackson RR. Influence of diuretics, calcium antagonists, and alpha-blockers on insulin sensitivity and glucose tolerance in hypertensive patients. J Cardiovasc Pharrnacol. 1992; 20(suppl 11):S49-S53.
17. Harris MI, Haden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years. Diabetes. 1987;36:523-534.
18. Garcia-Rodriguez LA, Pfaff GM, Schumacher MC, Walker AM, Hoffmeister H. Replacement estrogen use and body mass index. Epidemiology. 1990;1:219-223.
19. Spellacy WN, Buhi WC, Birk SA. The effect of estrogens on carbohydrate metabolism: glucose, insulin, and growth hormone studies on one hundred and seventy-one women ingesting Premarin, mestranol, and ethinyl estradiol for six months. Am J Obstet Gynecol. 1972;114:378-392.
20. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, Melis GB. Effects of low doses of transdermal 17B-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab. 1992;74:1396.
21. Godsland I, Gangar K, Walton C, et al. Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism. 1993;42:846-853.
22. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273:199-208.